ClinicalTrials.gg
RecruitingNCT07584070Updated Nov 19, 2026

Mystical Experiences Without Psychedelics and How Integration Improves Well-Being in Adults

An interventional study of Guided Invocation for Mystical Experience in Healthy Adult Participants, sponsored by Baylor University. Recruiting at 1 site in United States. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2026-11-19.

Sponsored by Baylor University · Not applicable, Interventional, and Health services research

How we know

From the registry’s dates

  • Started Jun 2026; still recruiting 5 months later.
Updated Nov 19, 2026Now RecruitingSite recruiting status changed+1 moreGo to Updates ↓

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Phase
Not applicable
Study type
Interventional
Enrollment
120
Allocation
Randomized
Ages
18 Years and older
Sex
All
01

Study summary

The goal of this clinical trial is to evaluate whether a guided, non-drug spiritual intervention can facilitate mystical-type experiences and improve well-being in Christian adults.

The main questions it aims to answer are:

  • Does the guided spiritual intervention produce measurable mystical experiences?
  • Does participation in the intervention and assigned integration program lead to improvements in well-being over time?

Researchers will compare a Christian-based integration program to a structured control integration program to determine whether Christian-based integration leads to greater improvements in well-being.

Participants will:

  • Complete baseline questionnaires assessing spiritual experiences, religiosity, and well-being
  • Complete one in-person session of the "guided invocation for mystical experience"
  • Be randomly assigned to complete either a Christian-based or control integration program for 4 weeks
  • Complete follow-up assessments at 1 month and 2 months
Read the detailed description

Mystical-type experiences involve acute alterations in consciousness characterized by features such as perceived unity, transcendence of time and space, positive affect, and a sense of encountering ultimate reality. These experiences have been associated with sustained changes in psychological well-being and meaning-making. Most contemporary empirical research has examined such experiences in the context of psychedelic substances; however, non-pharmacological methods for facilitating these experiences remain understudied despite historical precedent and preliminary evidence of feasibility.

This study evaluates a standardized, non-drug intervention, the Guided Invocation for Mystical Experience (GIME), designed to facilitate mystical-type experiences through induction of a non-ordinary state of consciousness. The intervention integrates controlled breathing techniques, guided imagery, and structured verbal suggestion. These components are intended to increase attentional absorption, reduce external sensory input, and promote alterations in perception and self-referential processing consistent with prior models of altered states of consciousness.

The intervention is informed by a conceptual framework in which the occurrence of mystical-type experiences is influenced by three primary factors: (1) induction of a non-ordinary state of consciousness, (2) contextual variables (e.g., environmental setting, expectancy), and (3) structured evocative instructions ("invitation"). The protocol standardizes these elements to enhance reproducibility and reduce variability across participants.

The GIME session is administered in person by a trained practitioner using a manualized procedure. The session includes (1) preparatory instructions and rapport establishment, (2) a structured breathing protocol designed to facilitate physiological and attentional changes, (3) guided imagery and verbal suggestions targeting core dimensions of mystical-type experiences (e.g., unity, sacredness, positive affect), and (4) a brief period of unstructured experiential processing followed by re-alerting procedures. The intervention is designed to be completed within a single session.

Following the intervention, participants are randomized to one of two post-session integration conditions. Integration is conceptualized as an active cognitive and behavioral process through which individuals interpret and incorporate the experience into their existing belief systems and daily functioning. The experimental condition consists of a structured, Christian-oriented integration program including psychoeducational materials, guided reflection exercises, brief recorded audio sessions, and weekly phone calls from the interventionist. The control condition consists of a structurally equivalent program matched for duration, attention, and task engagement but without religious or spiritual content. This comparison allows for evaluation of the specific effects of faith-based integration practices.

The study also examines potential moderating variables influencing both the occurrence and intensity of mystical-type experiences, including baseline religiosity, spirituality, and trait-level factors associated with absorption and responsiveness to altered states of consciousness. These variables are hypothesized to predict variability in experiential outcomes and downstream effects.

This trial is designed to (1) evaluate the feasibility and efficacy of a manualized, non-pharmacological intervention for facilitating mystical-type experiences, (2) characterize the phenomenology of these experiences in a religious sample, and (3) assess the extent to which structured integration practices influence the durability of changes in well-being over time.

02

Conditions studied

  • Healthy Adult Participants

Keywords

  • mystical experience
  • peak spiritual experience
  • integration
  • hypnosis
03

In context

Lead sponsor

Baylor University is the lead sponsor of 42 studies on the registry; 9 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • age 18 years or older;
  • active Christian faith;
  • willing to experience hypnosis;
  • English-speaking; able to complete one in-person session and 1- and 2-month follow-up assessments.

Exclusion criteria

Exclusion Criteria:

  • prior psychedelic use;
  • severe mental illness (e.g., schizophrenia, bipolar disorder, psychosis, borderline personality disorder);
  • unwillingness to experience hypnosis;
  • inability to complete study procedures
05

Study design

Phase
Not applicable
Primary purpose
Health services research
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Single (Outcomes assessor)
Enrollment
120 participants (estimated)

Study arms

  • Experimental
    Structured Christian Integration

    Participants assigned to the structured Christian integration condition will engage in a 4-week, integration program designed to facilitate reflection on and incorporation of their peak spiritual experience into their existing religious framework. The intervention includes four modules with psychoeducational materials, structured activities grounded in Christian teachings, and weekly phone calls with the interventionist. Participants will use a toolkit with weekly writing prompts and recorded audio sessions (14-22 minutes) focused on themes such as revisiting and reflection, awareness and nature, love and connection, and transformation. Participants will engage with materials regularly (e.g., audio sessions at least four times per week) and submit written responses at the end of each module. The program is standardized and designed to support ongoing cognitive and emotional processing and integration into daily life and religious practice.

    Behavioral: Guided Invocation for Mystical Experience

  • Active comparator
    Structured Control Integration

    Participants assigned to the structured control integration condition will engage in a 4-week, self-guided program designed to match the structure, duration, and level of engagement of the Christian integration condition. The intervention includes four modules with psychoeducational materials, structured poetry analysis without religious or spiritual content, and weekly phone calls with the interventionist. Participants will use a toolkit with weekly writing prompts and audio sessions focused on various analyses (e.g., content, structure, imagery, symbolism) of poetry. Participants will engage with materials regularly (e.g., audio sessions at least four times per week) and submit written responses at the end of each module. The program is standardized and designed as a structurally equivalent control condition and no specific benefit is anticipated.

    Behavioral: Guided Invocation for Mystical Experience

Interventions

  • BehavioralGuided Invocation for Mystical Experience

    Participants will complete a single, in-person Guided Invocation for Mystical Experience (GIME) session conducted by a trained practitioner using a standardized protocol. The session includes an initial briefing and rapport-building period, followed by a structured breathing exercise (approximately 8 minutes) designed to facilitate a non-ordinary state of consciousness. Participants then receive guided imagery and verbal suggestions intended to promote relaxation, absorption, and experiential openness. The practitioner delivers a standardized script targeting features commonly associated with mystical-type experiences (e.g., unity, positive affect, and altered perception of time and space). The session includes a brief period of silent introspection, followed by re-alerting procedures. The total session duration is approximately 60 minutes.

06

What researchers measure

Primary outcomes

  1. Frequency of a Complete Mystical Experience as Assessed by the Mystical Experience Questionnaire

    Frequency of complete mystical experiences will be assessed using the 30-item Mystical Experience Questionnaire (MEQ30), a validated self-report measure designed to assess key phenomenological features of mystical-type experiences. The MEQ30 includes four empirically derived subscales: Mystical, Positive Mood, Transcendence of Time and Space, and Ineffability. Participants rate the extent to which each item describes their experience. Higher scores reflect greater endorsement of mystical-type features. To determine whether a participant had a complete mystical experience, scores will be calculated for each of the four subscales and expressed as a percentage of the maximum possible score for that subscale. A complete mystical experience is defined as meeting or exceeding 60% of the maximum possible score on all four MEQ30 subscales. The frequency of complete mystical experiences will then be calculated as the proportion of participants who meet this criteria.

    Time frame: Immediately following the in-person guided invocation for mystical experience session

  2. PERMA Well-Being Scale

    The PERMA Well-Being Scale measures five dimensions of well-being-Positive Emotion, Engagement, Relationships, Meaning, and Accomplishment-based on Martin Seligman's PERMA model. The scale contains 23 items, with 3-5 items per subdomain, scored on a Likert scale. Butler and Kern (2016) established the scale's internal consistency (α \> .80) and construct validity.

    Time frame: Baseline, 1 month, and 2 months post-intervention

  3. Ryff Psychological Wellbeing Scale

    The Ryff Psychological Wellbeing Scale (PWB) assesses six domains of well-being: autonomy, environmental mastery, personal growth, positive relationships, purpose in life, and self-acceptance. It includes 42 items, scored on a Likert scale, with shorter versions available. Psychometric evaluation revealed high internal consistency (α \> .80) and test-retest reliability across diverse populations (Ryff \& Keyes, 1995). Example items include, "I like most parts of my personality" (self-acceptance) and "I am not afraid to voice my opinions, even when they are in opposition to most people" (autonomy).

    Time frame: Baseline, 1 month, and 2 months post-intervention

  4. Multidimensional Existential Meaning Scale

    The Multidimensional Existential Meaning Scale (MEMS) measures existential meaning across three dimensions: coherence, purpose, and mattering. The scale consists of 15 items rated on a 7-point Likert scale ranging from "strongly disagree" to "strongly agree." Higher scores indicate a greater sense of existential meaning. Psychometric evaluations by George and Park (2017) demonstrated excellent internal consistency (α \> .90) and robust construct validity. Example items include, "I understand how my life fits into the larger picture," "I feel that my life has a clear sense of purpose," and "I believe that my life is significant and matters." This scale is particularly suited for studies exploring the depth and breadth of meaning in individuals' lives.

    Time frame: Baseline, 1 month, and 2 months post-intervention

  5. Flourishing Scale

    The Flourishing Scale measures social-psychological prosperity across eight items that assess areas such as self-esteem, purpose, and optimism. Items are rated on a 7-point Likert scale, with higher scores indicating greater well-being. Diener et al. (2010) demonstrated excellent internal consistency (α \> .85). An example item is, "I lead a purposeful and meaningful life." This concise yet comprehensive scale is widely used in studies of well-being interventions.

    Time frame: Baseline, 1 months, and 2 months post-intervention

  6. Quality of Life Rating Scale

    The Quality of Life Rating Scale evaluates life satisfaction across physical, emotional, and social domains. The 16-item measure uses a 7-point Likert scale, with higher scores reflecting better quality of life. Burckhardt and Anderson (2003) reported strong psychometric properties, including internal consistency (α \> .80). A sample item is, "To what degree do you feel your physical health limits your activities of daily living?"

    Time frame: Baseline, 1 month, and 2 months post-intervention

  7. Spiritual Transcendence Scale

    The Spiritual Transcendence Scale measures the degree of an individual's sense of connectedness to a higher reality. The scale contains 24 items across three subdomains: prayer fulfillment (α = .85), universality (α = .85), and connectedness (α = .65). Piedmont (1999) reported good internal consistency on three subscales. Example items include, "I find strength in my religion or spirituality" (prayer fulfillment) and "I feel a sense of oneness with all humanity" (universality).

    Time frame: Baseline, 1 month, and 2 months post-intervention

  8. Religious and Spiritual Struggles Scale

    The Religious and Spiritual Struggles Scale (RSSS) measures the extent and nature of struggles individuals may have with their religion or spirituality. The scale includes 26 items and identifies six distinct domains of struggle: divine, demonic, interpersonal, moral, doubt, and ultimate meaning. Items are rated on a Likert scale, typically ranging from "not at all" to "a great deal," indicating the degree of struggle experienced. Exline et al. (2014) demonstrated strong internal consistency across subscales (α \> .80) and solid construct validity in both clinical and non-clinical populations. Sample items include, "I felt angry at God," "I struggled with feeling rejected or unloved by my religious community," and "I questioned whether my life really matters."

    Time frame: Baseline, 1 month, and 2 months post-intervention

  9. Attachment to God Scale

    The Attachment to God Scale (AGS) assesses individual differences in the quality of one's relationship with God, conceptualized through the lens of attachment theory. The scale consists of 9 items measuring two core dimensions: Anxiety (e.g., fear of abandonment by God) and Avoidance (e.g., discomfort with closeness to God). Participants rate each item on a 7-point Likert scale ranging from "strongly disagree" to "strongly agree." Higher scores on each subscale indicate greater attachment-related insecurity in the corresponding domain. Rowatt and Kirkpatrick (2002) demonstrated high internal consistency (α \> .85) for both subscales and strong construct validity, including associations with religious coping, mental health, and interpersonal relationships.

    Time frame: Baseline, 1 month, and 2 months post-intervention

  10. Self-Compassion Scale

    The Self-Compassion Scale (SCS) is a 26 question self-report scale designed to measure kindness and understanding toward oneself in instances of pain or failure (Neff, 2003). It has six factors including self-kindness, self-judgment, common humanity, isolation, mindfulness, and over-identification. The internal consistency was α = .92. A non-significant correlation of r = .05 (p = .34) was found between the SCS and the Marlowe-Crowne Social Desirability scale. The SCS was also found to have good construct and discriminant validity as well as test-retest reliability (r = .93).

    Time frame: Baseline, 1 month, and 2 months post-intervention

Secondary outcomes

  1. Brief Multidimensional Measure of Religiousness/Spirituality

    The Brief Multidimensional Measure of Religiousness/Spirituality (BMMRS) is a comprehensive tool designed to assess various dimensions of religious and spiritual life. The measure includes 29 items spanning multiple subdomains, such as religious practices (e.g., attendance at services, prayer), spiritual beliefs (e.g., beliefs in higher powers), coping strategies, and spiritual experiences. Items are rated on Likert scales or categorical responses, depending on the subdomain. The BMMRS has demonstrated strong psychometric properties, with internal consistency typically exceeding α = .80 across its subscales and evidence of validity in diverse cultural and religious populations.

    Time frame: Baseline

  2. Modified Tellegen Absorption Scale

    The Modified Tellegen Absorption Scale (MODTAS) is a revised version of the original Tellegen Absorption Scale, designed to assess an individual's tendency to become fully engaged in sensory and imaginative experiences. It includes 34 items rated on a 5-point Likert scale from "not at all true" to "extremely true," improving upon the original true/false format to enhance psychometric robustness. The MODTAS measures various aspects of experiential absorption, including responsiveness to engaging stimuli, imaginative involvement, and altered states of consciousness. Jamieson (2005) reported strong internal consistency (α \> .90) and construct validity in relation to hypnotizability and imaginative suggestibility.

    Time frame: Baseline

  3. Qualitative Characteristics of the Experience

    Thematic analysis of participant-reported experiences collected via post-session interviews.

    Time frame: Immediately following the in-person guided invocation for mystical experience session.

  4. Mysticism Scale

    The Mysticism Scale evaluates mystical experiences, focusing on dimensions such as ineffability, transcendence of time and space, and unity. It includes 32 items, rated on a Likert scale, and has been validated in multiple cultural contexts (Hood et al., 2001). Hood (1975) reported strong psychometric properties, with internal consistency above α = .80. An example item is, "I have had an experience where everything seemed to disappear, leaving only a sense of unity."

    Time frame: Immediately following the in-person guided invocation for mystical experience session

  5. Daily Spiritual Experience Scale

    The Daily Spiritual Experience Scale (DSES) measures the frequency of spiritual experiences in everyday life, focusing on feelings of connection, awe, gratitude, and a sense of divine presence. The scale includes 16 items rated on a 6-point Likert scale ranging from "many times a day" to "never or almost never," with higher scores reflecting greater frequency of daily spiritual experiences. Psychometric evaluations by Underwood and Teresi (2002) demonstrated excellent internal consistency (α \> .90) and strong validity across diverse religious and non-religious populations. Sample items include, "I feel God's presence" and "I feel a deep inner peace or harmony." The DSES is particularly suited for studies investigating spirituality as an experiential and moment-to-moment construct.

    Time frame: Baseline

  6. Religious Commitment Inventory-10

    The Religious Commitment Inventory-10 (RCI-10) assesses the degree to which religious beliefs and practices influence an individual's daily life and decisions. The scale consists of 10 items rated on a 5-point Likert scale from "not at all true of me" to "totally true of me." Higher scores indicate greater religious commitment. Worthington et al. (2003) reported excellent psychometric properties, including high internal consistency (α \> .90) and predictive validity for religious behavior and its impact on psychological outcomes.

    Time frame: Baseline

  7. Mysticism Scale - Lifetime

    The Mysticism Scale - Lifetime measures the frequency and intensity of mystical experiences throughout a person's life. Based on the regular Mysticism Scale, the lifetime scale comprises 32 items divided into three subdomains: introvertive mysticism, extrovertive mysticism, and interpretation of mystical experiences. It evaluates core aspects such as unity, ineffability, and transcendence of time and space. Hood (1975) validated the measure, reporting high internal consistency (α \> .80) and demonstrating its cross-cultural applicability in later studies (Hood et al., 2001).

    Time frame: Baseline, 1 month, and 2 months post-intervention

  8. 5-Dimensional Altered States of Consciousness Rating Scale

    The 5-Dimensional Altered States of Consciousness Rating Scale (5D-ASC) assesses altered states across five dimensions: oceanic boundlessness, anxious ego dissolution, visionary restructuralization, auditory alterations, and vigilance reduction. The scale contains 94 items, rated on a visual analog scale. Dittrich (1998) reported robust psychometric properties, with internal consistency exceeding α = .85. Sample items include, "I felt an all-encompassing unity" and "I perceived the world in a fundamentally new way."

    Time frame: Immediately after the in-person guided invocation for a mystical experience session

  9. Persisting Effects Questionnaire

    The Persisting Effects Questionnaire (Griffiths et al., 2006) assesses long-term changes in attitudes, moods, and behaviors following significant mystical experiences. The 89-item measure evaluates changes in spirituality, relationships, and life satisfaction.

    Time frame: 1 month and 2 months post-intervention

  10. Behavioral Indicator of Prosociality

    Participants will be given an option to donate some or all of their monetary compensation. Participants will be informed of which charitable organizations their donation will benefit. This will be measured in dollar amounts and compared between the experimental conditions.

    Time frame: 1 month and 2 months post-intervention

  11. Personal Significance Questions

    The following personal significance questions are based on those used in psychedelic-assisted therapy trials (e.g., Griffiths et al., 2006) How personally meaningful was the experience you had during your in-person session? Participants will respond with one of 8 responses ranging from "no more than routine, everyday experiences" to "the single most meaningful experience of my life" Indicate the degree to which the experience was spiritually significant to you. Participants will response with one of 6 responses ranging from "not at all" to "the single most spiritually significant experience of my life". To what degree did the experience and your contemplation of the experience lead to changes in your sense of personal well-being or life satisfaction? Participants will respond on a 7-point Likert scale ranging from "increased very much" to "decreased very much".

    Time frame: 1 month and 2 months post-intervention

  12. Brief Remote Elkins-Alldredge Test of Hypnotizability

    The Brief Remote Elkins-Alldredge Test of Hypnotizability is a virtual assessment based on the gold standard measure for hypnotizability, the Elkins Hypnotizability Scale (Muñiz et al., in press). The EHS is a 6 item, therapist-administered scale of hypnotizability. The six items include arm heaviness or immobilization, arm levitation, imagery involvement or dissociation, positive hallucination of the smell of a rose, positive hallucination of a block, and posthypnotic amnesia. Scoring is based on the respondent's subjective experience and observable behavioral responses which are summed to obtain a total score (range 0-12) with higher scores indicating greater hypnotizability. Categorizations of hypnotizability include low (1-4), moderate (5-8), and high (8-12). Validation studies have demonstrated that the EHS has good internal consistency in an outpatient clinical sample (a = .85; Elkins, 2014) and in a college student sample (a = .78; Kekecs et al., 2016).

    Time frame: 1 month post-intervention

  13. Hospital Anxiety and Depression Scale

    The Hospital Anxiety and Depression Scale (HADS) assesses the symptom severity of anxiety disorders and depression (Zigmond \& Snaith, 1983). It has strong internal consistency. A recent literature review of 747 papers found an average Cronbach's alphas of .83 for the anxiety subscale and .82 for the depression subscale. It also has acceptable to strong convergent validity. It performs well as an assessment tool in somatic, psychiatric, and primary care patients as well as in the general population (Bjelland et al., 2002).

    Time frame: Baseline, 1 month, and 2 months post-intervention

Other outcomes

  1. Acceptability questions

    If given the opportunity, how likely would you be to participate in this activity again? How likely are you to recommend this experience to others? Both of these questions will be answered on a 0-10 scale where 0 = not at all likely and 10 = extremely likely.

    Time frame: Immediately after the in-person guided invocation for a mystical experience session

  2. Self-identified spirituality

    In whatever way you define it, how spiritual do you consider yourself to be? Participants will respond to this question on a 0-100 visual analog scale where 0 = not at all spiritual and 100 = extremely spiritual.

    Time frame: Baseline, 1 month, and 2 months post-intervention

07

Study locations

1 of 1 sites recruiting
  • Mind-Body Medicine Research Laboratory
    Waco, Texas 76112, United States
    Recruiting
    • Gary Elkins, PhD · Contactgary_elkins@baylor.edu · 254-913-3026
    • Sarah Schnitker, PhD · Sub investigator
    • Devan Stahl, PhD · Sub investigator
    • Cameron Alldredge, PhD · Sub investigator
    • Erin Moniz, DMin · Sub investigator
    • Aaron Zimmerman, MDiv · Sub investigator
08

References and documents

Publications

  • Zigmond AS, Snaith RP. The hospital anxiety and depression scale. Acta Psychiatr Scand. 1983 Jun;67(6):361-70. doi: 10.1111/j.1600-0447.1983.tb09716.x. PubMed 6880820 ↗
  • Neff, K. D. (2003). The Development and Validation of a Scale to Measure Self-Compassion. Self & Identity, 2(3), 223. (10182182). https://doi.org/10.1080/15298860309027
  • Bjelland I, Dahl AA, Haug TT, Neckelmann D. The validity of the Hospital Anxiety and Depression Scale. An updated literature review. J Psychosom Res. 2002 Feb;52(2):69-77. doi: 10.1016/s0022-3999(01)00296-3. PubMed 11832252 ↗
  • Yaden DB, Griffiths RR. The Subjective Effects of Psychedelics Are Necessary for Their Enduring Therapeutic Effects. ACS Pharmacol Transl Sci. 2020 Dec 10;4(2):568-572. doi: 10.1021/acsptsci.0c00194. eCollection 2021 Apr 9. PubMed 33861219 ↗
  • Watts, R., & Luoma, J. B. (2020). The use of the psychological flexibility model to support psychedelic assisted therapy. Journal of Contextual Behavioral Science, 15, 92-102. https://doi.org/10.1016/j.jcbs.2019.12.004
  • Tart CT. Psychedelic experiences associated with a novel hypnotic procedure, mutual hypnosis. Am J Clin Hypn. 1967 Oct;10(2):65-78. doi: 10.1080/00029157.1967.10401952. No abstract available. PubMed 6080106 ↗
  • Stace, W. T. (1960). Mysticism and philosophy (1st ed.). J. B. Lippincott.
  • Slonena EE, Elkins GR. Effects of a Brief Mindful Hypnosis Intervention on Stress Reactivity: A Randomized Active Control Study. Int J Clin Exp Hypn. 2021 Oct-Dec;69(4):453-467. doi: 10.1080/00207144.2021.1952845. Epub 2021 Jul 30. PubMed 34330204 ↗
  • Sacerdote P. Applications of hypnotically elicited mystical states to the treatment of physical and emotional pain. Int J Clin Exp Hypn. 1977 Oct;25(4):309-24. doi: 10.1080/00207147708415987. No abstract available. PubMed 330419 ↗
  • Moujaes F, Rieser NM, Phillips C, de Matos NMP, Brugger M, Durler P, Smigielski L, Stampfli P, Seifritz E, Vollenweider FX, Anticevic A, Preller KH. Comparing Neural Correlates of Consciousness: From Psychedelics to Hypnosis and Meditation. Biol Psychiatry Cogn Neurosci Neuroimaging. 2024 May;9(5):533-543. doi: 10.1016/j.bpsc.2023.07.003. Epub 2023 Jul 17. PubMed 37459910 ↗
  • Miller WR. The phenomenon of quantum change. J Clin Psychol. 2004 May;60(5):453-60. doi: 10.1002/jclp.20000. PubMed 15048692 ↗
  • Macallan, B. C. (2023). Christian responses to psilocybin-assisted therapy and potential religious and spiritual experiences. Religions, 14(10), 1312.
  • KRIPPNER S. THE HYPNOTIC TRANCE, THE PSYCHEDELIC EXPERIENCE, AND THE CREATIVE ACT. Am J Clin Hypn. 1964 Oct;7:140-7. doi: 10.1080/00029157.1964.10402408. No abstract available. PubMed 14215079 ↗
  • Ko K, Knight G, Rucker JJ, Cleare AJ. Psychedelics, Mystical Experience, and Therapeutic Efficacy: A Systematic Review. Front Psychiatry. 2022 Jul 12;13:917199. doi: 10.3389/fpsyt.2022.917199. eCollection 2022. PubMed 35923458 ↗
  • Hashimoto K. Are "mystical experiences" essential for antidepressant actions of ketamine and the classic psychedelics? Eur Arch Psychiatry Clin Neurosci. 2025 Aug;275(5):1333-1346. doi: 10.1007/s00406-024-01770-7. Epub 2024 Feb 27. PubMed 38411629 ↗
  • Hartogsohn I. Set and setting, psychedelics and the placebo response: An extra-pharmacological perspective on psychopharmacology. J Psychopharmacol. 2016 Dec;30(12):1259-1267. doi: 10.1177/0269881116677852. Epub 2016 Nov 16. PubMed 27852960 ↗
  • HALPERN S. On the similarity between hypnotic and mescaline hallucinations. Int J Clin Exp Hypn. 1961 Jul;9:139-49. doi: 10.1080/00207146108409669. No abstract available. PubMed 13710923 ↗
  • Evans, J., & Lynn, S. J. (2021). Effects of hypnosis, suggestion, and implementation intention instructions on mystical-type experiences: A replication and extension. Psychology of Consciousness: Theory, Research, and Practice. https://doi.org/10.1037/cns0000278
  • Estiningsih, D., Setiawan, W., Rizkiana, A., Banna, U. A., Masitoh, & Muahhadah, F. (2024). Peak experience: The phenomenon of spirituality in religions and psychological problems (Islam, buddhism, catholicism). Advances in Social Science, Education and Humanities Research, 1248-1264. https://doi.org/10.2991/978-2-38476-273-6_128
  • Elkins GR, Barabasz AF, Council JR, Spiegel D. Advancing research and practice: the revised APA Division 30 definition of hypnosis. Int J Clin Exp Hypn. 2015;63(1):1-9. doi: 10.1080/00207144.2014.961870. PubMed 25365125 ↗
  • Cristofori I, Bulbulia J, Shaver JH, Wilson M, Krueger F, Grafman J. Neural correlates of mystical experience. Neuropsychologia. 2016 Jan 8;80:212-220. doi: 10.1016/j.neuropsychologia.2015.11.021. Epub 2015 Nov 26. PubMed 26631541 ↗
  • Creswell JD, Pacilio LE, Lindsay EK, Brown KW. Brief mindfulness meditation training alters psychological and neuroendocrine responses to social evaluative stress. Psychoneuroendocrinology. 2014 Jun;44:1-12. doi: 10.1016/j.psyneuen.2014.02.007. Epub 2014 Feb 23. PubMed 24767614 ↗
  • Coder, K. E. (2017). After the Ceremony Ends: A Companion Guide to Help You Integrate Visionary Plant Medicine Experiences. Shine Mojo, LLC
  • Clark-Soles, J. (2024). Psychedelics, the Bible, and the Divine. Religions, 15(5), 582. https://doi.org/10.3390/rel15050582
  • Carhart-Harris RL, Roseman L, Haijen E, Erritzoe D, Watts R, Branchi I, Kaelen M. Psychedelics and the essential importance of context. J Psychopharmacol. 2018 Jul;32(7):725-731. doi: 10.1177/0269881118754710. Epub 2018 Feb 15. PubMed 29446697 ↗
  • Cardena E, Jonsson P, Terhune DB, Marcusson-Clavertz D. The neurophenomenology of neutral hypnosis. Cortex. 2013 Feb;49(2):375-85. doi: 10.1016/j.cortex.2012.04.001. Epub 2012 Apr 11. PubMed 22579225 ↗
  • Cardena E. The phenomenology of deep hypnosis: quiescent and physically active. Int J Clin Exp Hypn. 2005 Jan;53(1):37-59. doi: 10.1080/00207140490914234. PubMed 15788243 ↗
  • Capps, D. (1985). Religion and Psychological Well-Being. In P. E. Hammond (Ed.), The Sacred in a Secular Age: Toward Revision in the Scientific Study of Religion (pp. 237-256). essay, Univ. of California Press.
  • Bathje GJ, Majeski E, Kudowor M. Psychedelic integration: An analysis of the concept and its practice. Front Psychol. 2022 Aug 4;13:824077. doi: 10.3389/fpsyg.2022.824077. eCollection 2022. PubMed 35992410 ↗
  • Barrett FS, Griffiths RR. Classic Hallucinogens and Mystical Experiences: Phenomenology and Neural Correlates. Curr Top Behav Neurosci. 2018;36:393-430. doi: 10.1007/7854_2017_474. PubMed 28401522 ↗
  • Evans, J., & Lynn, S. J. (2021). Effects of hypnosis, suggestion, and implementation intention instructions on mystical-type experiences: A replication and extension. Psychology of Consciousness: Theory, Research, and Practice, 11(3), 375-391. https://doi.org/10.1037/cns0000278
  • Corlett CE, Alldredge CT, Elkins GR. Feasibility of a Hypnosis Intervention for a Mystical Experience. Int J Clin Exp Hypn. 2025 Oct-Dec;73(4):414-431. doi: 10.1080/00207144.2025.2491352. Epub 2025 May 15. PubMed 40373220 ↗
  • Alldredge CT, Vagner M, Corlett C, Elkins GR. Clinical Utility of Mystical Experiences: An Overview and Conceptual Framework. Int J Clin Exp Hypn. 2025 Oct-Dec;73(4):432-448. doi: 10.1080/00207144.2025.2526351. Epub 2025 Jul 21. PubMed 40690713 ↗
  • Adams PJ. Language, mysticism, and hypnotizability: a brief communication. Int J Clin Exp Hypn. 2008 Jan;56(1):73-82. doi: 10.1080/00207140701673100. PubMed 18058488 ↗
  • Kekecs Z, Bowers J, Johnson A, Kendrick C, Elkins G. The Elkins Hypnotizability Scale: Assessment of Reliability and Validity. Int J Clin Exp Hypn. 2016 Jul-Sep;64(3):285-304. doi: 10.1080/00207144.2016.1171089. PubMed 27267674 ↗
  • Fetzer Institute/National Institute on Aging Working Group. (2003). Multidimensional Measurement of Religiousness/Spirituality for Use in Health Research: A Report of the Fetzer Institute/National Institute on Aging Working Group. Kalamazoo, MI: Fetzer Institute.
  • Baum LD. Hypnotic relaxation therapy: principles and applications by gary elkins. Am J Clin Hypn. 2014 Jul;57(1):80-1. doi: 10.1080/00029157.2015.917568. No abstract available. PubMed 25928488 ↗
  • Griffiths RR, Richards WA, McCann U, Jesse R. Psilocybin can occasion mystical-type experiences having substantial and sustained personal meaning and spiritual significance. Psychopharmacology (Berl). 2006 Aug;187(3):268-83; discussion 284-92. doi: 10.1007/s00213-006-0457-5. Epub 2006 Jul 7. PubMed 16826400 ↗
  • Muniz V, Alldredge C, Elkins G. Reliability and Validity of the Brief Remote Elkins Alldredge Test of Hypnotizability (BREATH) in a College Student Population. Int J Clin Exp Hypn. 2026 Jan 20:1-10. doi: 10.1080/00207144.2025.2594995. Online ahead of print. PubMed 41557864 ↗
  • Dittrich A. The standardized psychometric assessment of altered states of consciousness (ASCs) in humans. Pharmacopsychiatry. 1998 Jul;31 Suppl 2:80-4. doi: 10.1055/s-2007-979351. PubMed 9754838 ↗
  • Barrett FS, Johnson MW, Griffiths RR. Validation of the revised Mystical Experience Questionnaire in experimental sessions with psilocybin. J Psychopharmacol. 2015 Nov;29(11):1182-90. doi: 10.1177/0269881115609019. Epub 2015 Oct 6. PubMed 26442957 ↗
  • Rowatt, W. C., & Kirkpatrick, L. A. (2002). Two dimensions of attachment to God and their relation to affect, religiosity, and personality constructs. Journal for the Scientific Study of Religion, 41(4), 637-651. https://doi.org/10.1111/1468-5906.00143
  • Exline, J. J., Pargament, K. I., Grubbs, J. B., & Yali, A. M. (2014). The Religious and Spiritual Struggles Scale: Development and initial validation. Psychology of Religion and Spirituality, 6(3), 208-222. https://doi.org/10.1037/a0036465
  • Piedmont, R. L. (1999). Does spirituality represent the sixth factor of personality? Journal of Personality, 67(6), 985-1013.
  • George, L. S., & Park, C. L. (2017). The Multidimensional Existential Meaning Scale: A tripartite approach to measuring meaning in life. Journal of Positive Psychology, 12(6), 613-627. https://doi.org/10.1080/17439760.2016.1209546
  • Ryff CD, Keyes CL. The structure of psychological well-being revisited. J Pers Soc Psychol. 1995 Oct;69(4):719-27. doi: 10.1037//0022-3514.69.4.719. PubMed 7473027 ↗
  • Ryff, C. D. (1989). Happiness is everything, or is it? Explorations on the meaning of psychological well-being. Journal of Personality and Social Psychology, 57(6), 1069-1081.
  • Worthington, E. L., Wade, N. G., Hight, T. L., Ripley, J. S., McCullough, M. E., Berry, J. W., Schmitt, M. M., Berry, J. T., Bursley, K. H., & O'Connor, L. (2003). The Religious Commitment Inventory--10: Development, refinement, and validation of a brief scale for research and counseling. Journal of Counseling Psychology, 50(1), 84-96. https://doi.org/10.1037/0022-0167.50.1.84
  • Underwood LG, Teresi JA. The daily spiritual experience scale: development, theoretical description, reliability, exploratory factor analysis, and preliminary construct validity using health-related data. Ann Behav Med. 2002 Winter;24(1):22-33. doi: 10.1207/S15324796ABM2401_04. PubMed 12008791 ↗
  • Masters, K.S. (2020). Brief Multidimensional Measure of Religiousness/Spirituality (BMMRS). In: Gellman, M.D. (eds) Encyclopedia of Behavioral Medicine. Springer, Cham. https://doi.org/10.1007/978-3-030-39903-0_1577
  • Jamieson, G. A. (2005). The modified Tellegen absorption scale: A clearer window on the structure and meaning of absorption. Australian Journal of Clinical and Experimental Hypnosis, 33(2), 119.
  • Diener, E., Wirtz, D., Tov, W., Kim-Prieto, C., Choi, D. W., Oishi, S., & Biswas-Diener, R. (2010). New well-being measures: Short scales to assess flourishing and positive and negative feelings. Social Indicators Research, 97(2), 143-156.
  • Butler, J., & Kern, M. L. (2016). The PERMA-Profiler: A brief multidimensional measure of flourishing. International Journal of Wellbeing, 6(3), 1-48.
  • Burckhardt, C. S., & Anderson, K. L. (2003). The Quality of Life Rating Scale: Psychometric properties and application in clinical populations. Quality of Life Research, 12(1), 55-63.

Individual participant data

Plan to share: Undecided

09

Timeline

1 registry update since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedDate before it movedWhere the date was before it moved

Started Jun 2026 (actual). Primary completion is estimated for Apr 2027, 10 months after the start.

Start moved once since we started tracking on Sep 25, 2026: Apr 2026 → Jun 2026, on Nov 19, 2026.

Earlier changes are on the record history on ClinicalTrials.gov ↗

How these figures are worked out, and which studies are left out of them.

Registered
May 7, 2026
First posted
May 13, 2026
StartActual
Jun 2, 2026was Apr 2026
Primary completionEst.
Apr 30, 2027
CompletionEst.
Aug 1, 2027
Last update
Nov 19, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
Status
Not yet recruiting→Recruiting
changed Nov 19, 2026
Sites
Mind-Body Medicine Research Laboratory is now Recruiting
Nov 19, 2026
Start date
Apr 2026→Jun 2, 2026 (actual)
Nov 19, 2026
Show all 1 update
  1. Nov 19, 2026
    Not yet recruiting→Recruiting
    Mind-Body Medicine Research Laboratory is now Recruiting
    Start date Apr 2026→Jun 2, 2026 (now actual)
    + 1 other change: verification date

From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗

10

Registry details

Key details

Study ID
NCT07584070
Lead sponsor
Baylor University
Collaborators
Templeton World Charity Foundation
Responsible party
Sponsor
First posted
May 13, 2026
Start date
Jun 2, 2026
Primary completion
Apr 30, 2027 (estimated)
Completion
Aug 1, 2027 (estimated)
Last update
Nov 19, 2026

Study contacts

Gary Elkins, PhD
Contact
gary_elkins@baylor.edu
254-913-3026
Cameron Alldredge, PhD
Contact
cameron_alldredge@baylor.edu
254-265-8893
Gary Elkins, PhD
principal investigator · Baylor University

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion